Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Peritoneal Dialysis | Research

Pathogenic spectrum and risk factors of peritoneal dialysis-associated peritonitis: a single-center retrospective study

Authors: Linshuang You, Baoguo Zhang, Fan Zhang, Jianwen Wang

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

The present study aimed to explore the pathogenic spectrum and risk factors of peritoneal dialysis-associated peritonitis (Peritoneal dialysis associated peritonitis, PDAP) in Yongzhou, Hunan, China. The clinical and epidemiological data on regular peritoneal dialysis (Peritoneal dialysis, PD) between January 2016 and December 2020 in Yongzhou were collected for retrospective analysis. The related factors of peritonitis were evaluated by single-factor analysis, while risk factors of refractory PDAP were evaluated by multivariate logistic regression analysis.172/331 172 (51.9%) patients developed peritonitis. The risk factors of PDAP in PD patients included high C-reactive protein (C-reactive protein, CRP), low albumin(Albumin, ALB), low hemoglobin (Hemoglobin, Hb), low educational level (junior high school or lower), preference of spicy food, irregular diet, low annual household income, unfavorable fluid exchange conditions, unstable employment (including working as a farmer), and unfavorable humidity conditions (P < 0.05). 63/172 (36.6%) PDAP patients were intractable cases with a pathogenic bacteria positive rate of 74.60% in the peritoneal dialysate cultures, and 109/172 patients were non-intractable cases with a pathogenic bacteria positive rate of 53.21%. Gram-positive bacteria (G+) were detected in most of the dialysate cultures, with Staphylococcus epidermidis (S. epidermidis) as the most common type, while Escherichia coli (E. coli) was the most common Gram-negative bacteria (G-). Gram-positive bacteria were sensitive to vancomycin and linezolid, while G- bacteria were sensitive to imipenem and amikacin. Lifestyle, educational level, and environmental factors are the major contributors to PDAP in PD patients. Fungal and multi-bacterial infections are the major causes of death; PD is stopped for such patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference National Kidney Foundation. NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy [J]. Am J Kidney Dis. 1997;30(3 Suppl 2):S67–136. National Kidney Foundation. NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy [J]. Am J Kidney Dis. 1997;30(3 Suppl 2):S67–136.
2.
go back to reference Andy Tang SO, Carolisna YI, Sakura D, et al. Demo-graphic characteristics and outcomes of continuous ambulatory peritoneal dialysis related peritonitis in Miri General Hospital. Malaysia [J] Med J Malaysia. 2019;74(4):270–4.PubMed Andy Tang SO, Carolisna YI, Sakura D, et al. Demo-graphic characteristics and outcomes of continuous ambulatory peritoneal dialysis related peritonitis in Miri General Hospital. Malaysia [J] Med J Malaysia. 2019;74(4):270–4.PubMed
3.
go back to reference Lapic I, Padoan A, Bozzato D, et al. Erythrocyte sedimenta-tion rate and C -reactive protein in acute inflammation [J]. Am J Clin Pathol. 2020;153(1):14–29.CrossRefPubMed Lapic I, Padoan A, Bozzato D, et al. Erythrocyte sedimenta-tion rate and C -reactive protein in acute inflammation [J]. Am J Clin Pathol. 2020;153(1):14–29.CrossRefPubMed
4.
go back to reference Wu H, Ye H, Huang R, et al. Incidence and risk factors of peritoneal dialysis-related peritonitis in elderly patients: a retro-spective clinical study[J]. Perit Dial Int. 2020;40(1):26–33.CrossRefPubMed Wu H, Ye H, Huang R, et al. Incidence and risk factors of peritoneal dialysis-related peritonitis in elderly patients: a retro-spective clinical study[J]. Perit Dial Int. 2020;40(1):26–33.CrossRefPubMed
5.
go back to reference Wang HH, Huang CH, Kuo MC et al. Microbiology of peritoneal dialysis -related infection and factors of intractable peritoneal di -alysis related peritonitis: a ten -year single-center study inTaiwan [J]J microbiol Immunol Infect,2019,52 (5):752–9. Wang HH, Huang CH, Kuo MC et al. Microbiology of peritoneal dialysis -related infection and factors of intractable peritoneal di -alysis related peritonitis: a ten -year single-center study inTaiwan [J]J microbiol Immunol Infect,2019,52 (5):752–9.
6.
go back to reference Li PK, Chow KM, Cho Y, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment[J]. Perit Dial Int. 2022;42(2):110–53.CrossRefPubMed Li PK, Chow KM, Cho Y, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment[J]. Perit Dial Int. 2022;42(2):110–53.CrossRefPubMed
7.
go back to reference Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002 ⁃ 2003[J]. Perit Dial Int. 2009;29(3):297–302.CrossRefPubMed Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002 ⁃ 2003[J]. Perit Dial Int. 2009;29(3):297–302.CrossRefPubMed
9.
go back to reference Boudville N, Kemp A, Clayton P, et al. Recent peritonitis associates with mortality among patients treated with peritoneal dialysis[J]. J Am Soc Nephrol. 2012;23(8):1398–405.CrossRefPubMedPubMedCentral Boudville N, Kemp A, Clayton P, et al. Recent peritonitis associates with mortality among patients treated with peritoneal dialysis[J]. J Am Soc Nephrol. 2012;23(8):1398–405.CrossRefPubMedPubMedCentral
10.
go back to reference Ozturk S, Soyluk O, Karakaya D, et al. Is decline in serum albumin an ominous sign for subsequent peritonitis in peritoneal dialysis patients?[J]. Adv Perit Dial. 2009;25:172–7.PubMed Ozturk S, Soyluk O, Karakaya D, et al. Is decline in serum albumin an ominous sign for subsequent peritonitis in peritoneal dialysis patients?[J]. Adv Perit Dial. 2009;25:172–7.PubMed
11.
go back to reference Tian Y, Xie X, Xiang S, et al. Risk factors and outcomes of early ⁃ onset peritonitis in Chinese peritoneal dialysis patients[J]. Kidney Blood Press Res. 2017;42(6):1266–76.CrossRefPubMed Tian Y, Xie X, Xiang S, et al. Risk factors and outcomes of early ⁃ onset peritonitis in Chinese peritoneal dialysis patients[J]. Kidney Blood Press Res. 2017;42(6):1266–76.CrossRefPubMed
12.
go back to reference Tian Y, Xie X, Xiang S et al. Risk factors and outcomes of high peritonitis rate in continuous ambulatory peritoneal dialysis patients: a retrospective study[J]. Med (Baltimore) 2016, 95(49): e5569. Tian Y, Xie X, Xiang S et al. Risk factors and outcomes of high peritonitis rate in continuous ambulatory peritoneal dialysis patients: a retrospective study[J]. Med (Baltimore) 2016, 95(49): e5569.
13.
go back to reference Davies SJ, Zhao J, Morgenstern H, et al. Low serum potassium levels and clinical outcomes in peritoneal dialysis⁃International results from PDOPPS[J]. Kidney Int Rep. 2021;6(2):313–24.CrossRefPubMed Davies SJ, Zhao J, Morgenstern H, et al. Low serum potassium levels and clinical outcomes in peritoneal dialysis⁃International results from PDOPPS[J]. Kidney Int Rep. 2021;6(2):313–24.CrossRefPubMed
14.
go back to reference Chuang YW, Shu KH, Yu TM, et al. Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients[J]. Nephrol Dial Transpl. 2009;24(5):1603–8.CrossRef Chuang YW, Shu KH, Yu TM, et al. Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients[J]. Nephrol Dial Transpl. 2009;24(5):1603–8.CrossRef
15.
go back to reference Ribeiro SC, Figueiredo AE, Barretti P, et al. Low serum potassium levels increase the infectious ⁃ caused mortality in peritoneal dialysis patients: a propensity matched score study[J]. PLoS ONE. 2015;10(6):e0127453.CrossRefPubMedPubMedCentral Ribeiro SC, Figueiredo AE, Barretti P, et al. Low serum potassium levels increase the infectious ⁃ caused mortality in peritoneal dialysis patients: a propensity matched score study[J]. PLoS ONE. 2015;10(6):e0127453.CrossRefPubMedPubMedCentral
16.
go back to reference Liu D, Lin Y, Gong N, et al. Degree and duration of hypokalemia associated with peritonitis in patients undergoing peritoneal dialysis[J]. Int J Clin Pract. 2021;75(8):e14188.CrossRefPubMed Liu D, Lin Y, Gong N, et al. Degree and duration of hypokalemia associated with peritonitis in patients undergoing peritoneal dialysis[J]. Int J Clin Pract. 2021;75(8):e14188.CrossRefPubMed
17.
go back to reference Li PK, Szeto CC, Piraino B et al. Peritoneal dialysis related infections recommendations:2010 update[J]Perit Dial Int,2010,30(4):393–423. Li PK, Szeto CC, Piraino B et al. Peritoneal dialysis related infections recommendations:2010 update[J]Perit Dial Int,2010,30(4):393–423.
18.
19.
go back to reference Hibi,Arata et al. Kasugai. Peritoneal dialysis-associated catheter infection caused by Mycobacterium abscessus in an elderly patient who was successfully treated with catheter removal.[J].CEN Case Rep,2017. Hibi,Arata et al. Kasugai. Peritoneal dialysis-associated catheter infection caused by Mycobacterium abscessus in an elderly patient who was successfully treated with catheter removal.[J].CEN Case Rep,2017.
20.
go back to reference Yılmaz. Fatih,Bora Peritoneal Dialysis Related Peritonitis by Sphingomonas Paucimobilis.[J].Ther Apher Dial,2017. Yılmaz. Fatih,Bora Peritoneal Dialysis Related Peritonitis by Sphingomonas Paucimobilis.[J].Ther Apher Dial,2017.
21.
go back to reference Amanathan K, Padmanabhan G. V i jayaraghavan B.Evaluation of continuous ambulatory peritoneal dialysis fluid C-reactire protein in patients with peritonitis[J]. Saudi J Kidney Dis Transpl 2016, 27(3) : 467–72. Amanathan K, Padmanabhan G. V i jayaraghavan B.Evaluation of continuous ambulatory peritoneal dialysis fluid C-reactire protein in patients with peritonitis[J]. Saudi J Kidney Dis Transpl 2016, 27(3) : 467–72.
22.
go back to reference Zhu YQ, Chen J, Ying LJ, et al. Pathogenic bacteria,antibiotic resistance and prognosis of peritonitis in peritoneal dialysis patients[J]. J Clin Nephrol. 2018;32(5):198–203. Zhu YQ, Chen J, Ying LJ, et al. Pathogenic bacteria,antibiotic resistance and prognosis of peritonitis in peritoneal dialysis patients[J]. J Clin Nephrol. 2018;32(5):198–203.
23.
go back to reference Xiao-Jing L, Ling-Ju Y, Yong-Quan L et al. Clinical analysis of peritoneal dialysis-related peritonitis in a single center. 2017, 47(3):354–8. Xiao-Jing L, Ling-Ju Y, Yong-Quan L et al. Clinical analysis of peritoneal dialysis-related peritonitis in a single center. 2017, 47(3):354–8.
24.
go back to reference Wu H, Huang R, Yi C, et al. Risk factors for early-onset Peritonitis in Southern Chinese Peritoneal Dialysis Patients[J]. Perit Dial Int. 2016;36(6):640–6.CrossRefPubMedPubMedCentral Wu H, Huang R, Yi C, et al. Risk factors for early-onset Peritonitis in Southern Chinese Peritoneal Dialysis Patients[J]. Perit Dial Int. 2016;36(6):640–6.CrossRefPubMedPubMedCentral
25.
go back to reference Sukackiene,Diana et al. Rimsevicius. A case of successfully treated relapsing peritoneal dialysis-associated peritonitis caused by Gordonia bronchialis in a farmer.[J].Nephrol Ther,2017. Sukackiene,Diana et al. Rimsevicius. A case of successfully treated relapsing peritoneal dialysis-associated peritonitis caused by Gordonia bronchialis in a farmer.[J].Nephrol Ther,2017.
26.
go back to reference Ma,Ying. Wang Predictors of Short-term Outcomes of Patients with Peritoneal Dialysis-associated Peritonitis.[J].Zhongguo Yi Xue Ke Xue Yuan Xue Bao,2018,40(1):13–20. Ma,Ying. Wang Predictors of Short-term Outcomes of Patients with Peritoneal Dialysis-associated Peritonitis.[J].Zhongguo Yi Xue Ke Xue Yuan Xue Bao,2018,40(1):13–20.
27.
go back to reference Sarihan. Irem,Demir Serratia marcescens, Morganella morganii, Klebsiella oxytoca related peritonitis attacks in a patient on automated peritoneal dialysis: a case report.[J].Nefrologia,2017. Sarihan. Irem,Demir Serratia marcescens, Morganella morganii, Klebsiella oxytoca related peritonitis attacks in a patient on automated peritoneal dialysis: a case report.[J].Nefrologia,2017.
28.
go back to reference Shen SJ, Guan JC, Wang SM. Analysis of microbial spectrum and antibiotic resistance in 129 cases patients of peritoneal dialysis related peritonitis[J]. Chin J Gen Pract. 2018;35(5):389–95. Shen SJ, Guan JC, Wang SM. Analysis of microbial spectrum and antibiotic resistance in 129 cases patients of peritoneal dialysis related peritonitis[J]. Chin J Gen Pract. 2018;35(5):389–95.
29.
go back to reference Chen CM, Nephrology DO. Analysis and research of type and tolerance of 34 cases with peritoneal Dialysis-related Peritonitis pathogenic Bacteria[J]. Volume 29. China & Foreign Medical Treatment; 2017. pp. 673–9. 4. Chen CM, Nephrology DO. Analysis and research of type and tolerance of 34 cases with peritoneal Dialysis-related Peritonitis pathogenic Bacteria[J]. Volume 29. China & Foreign Medical Treatment; 2017. pp. 673–9. 4.
30.
go back to reference ,Chang Jae Hyun,Oh Jieun, Park Sue K et al. Frequent patient retraining at home reduces the risks of peritoneal dialysis-related infections:a randomised study.[J].Scientific reports,2018,8(1). ,Chang Jae Hyun,Oh Jieun, Park Sue K et al. Frequent patient retraining at home reduces the risks of peritoneal dialysis-related infections:a randomised study.[J].Scientific reports,2018,8(1).
31.
go back to reference BOUDVILLE N, JOHNSON D W, ZHAO J, et al. Regional Varia-Tion in the treatment and prevention of peritoneal dialysis-related infections in the peritoneal dialysis outcomes and practice patterns study[J]. Nephrol Dial Transpl. 2019;34(12):2118–26.CrossRef BOUDVILLE N, JOHNSON D W, ZHAO J, et al. Regional Varia-Tion in the treatment and prevention of peritoneal dialysis-related infections in the peritoneal dialysis outcomes and practice patterns study[J]. Nephrol Dial Transpl. 2019;34(12):2118–26.CrossRef
32.
go back to reference Yang J, Zhang WW, Wan C, et al. Analysis of antibiotic resistance in pathogenic bacteria from 91 episodes of peritoneal dialysis related peritonitis and its correlation to the prognosis of peritonitis[J]. Chin J Blood Purif. 2013;42(04):1202–6. Yang J, Zhang WW, Wan C, et al. Analysis of antibiotic resistance in pathogenic bacteria from 91 episodes of peritoneal dialysis related peritonitis and its correlation to the prognosis of peritonitis[J]. Chin J Blood Purif. 2013;42(04):1202–6.
33.
go back to reference Li T, Ping S, Hu Q, et al. Analysis of pathogens and prognosis in the elderly patients with peritoneal dialysis-related peritonitis[J]. Chin J Kidney Disease Investigation(Electronic Edition). 2018;45(4):377–80. Li T, Ping S, Hu Q, et al. Analysis of pathogens and prognosis in the elderly patients with peritoneal dialysis-related peritonitis[J]. Chin J Kidney Disease Investigation(Electronic Edition). 2018;45(4):377–80.
34.
go back to reference Auguste BL, Girsberger M, Kennedy C, et al. Are adverse events in newly trained home dialysis patients related to learning styles? A single-centre retrospective study from Toronto, Canada]〕]. BMJ Open. 2020;10(1):e033315.CrossRefPubMedPubMedCentral Auguste BL, Girsberger M, Kennedy C, et al. Are adverse events in newly trained home dialysis patients related to learning styles? A single-centre retrospective study from Toronto, Canada]〕]. BMJ Open. 2020;10(1):e033315.CrossRefPubMedPubMedCentral
35.
go back to reference Hu S, Tong R, Bo Y, et al. Fungal peritonitis in peritoneal dialy- sis: 5-year review from a North China center [ J]. Infection. 2018;47(1):35–43.CrossRefPubMed Hu S, Tong R, Bo Y, et al. Fungal peritonitis in peritoneal dialy- sis: 5-year review from a North China center [ J]. Infection. 2018;47(1):35–43.CrossRefPubMed
36.
go back to reference Morrisette T, Canada RB, Padgeitt D, et al. Factors associated with increased hospital length of stay in peritoneal dialysis patients with peritonitis : a need for antimicrobial stewardship? [J]. Hosp Pharm. 2020;55(1):50–7.CrossRefPubMed Morrisette T, Canada RB, Padgeitt D, et al. Factors associated with increased hospital length of stay in peritoneal dialysis patients with peritonitis : a need for antimicrobial stewardship? [J]. Hosp Pharm. 2020;55(1):50–7.CrossRefPubMed
37.
go back to reference Whitty. Rachel,Bargman Residual kidney function and Peritoneal Dialysis-Associated Peritonitis Treatment outcomes.[J].Clin J Am Soc Nephrol,2017. Whitty. Rachel,Bargman Residual kidney function and Peritoneal Dialysis-Associated Peritonitis Treatment outcomes.[J].Clin J Am Soc Nephrol,2017.
38.
go back to reference Kitterer D, Latus J, Pöhlmann C et al. Microbiological Surveillance of peritoneal dialysis associated peritonitis: susceptibility profiles of a referral center in Germany over 32 years[J].PLoS One,2015,10(9): e0135969. Kitterer D, Latus J, Pöhlmann C et al. Microbiological Surveillance of peritoneal dialysis associated peritonitis: susceptibility profiles of a referral center in Germany over 32 years[J].PLoS One,2015,10(9): e0135969.
39.
go back to reference Zeng Y, Jiang L, Lu Y, et al. Peritoneal dialysis-related Peritonitis caused by gram-negative organisms:ten-years experience in a single center[J]. Ren Fail. 2021;43(1):993–1003.CrossRefPubMedPubMedCentral Zeng Y, Jiang L, Lu Y, et al. Peritoneal dialysis-related Peritonitis caused by gram-negative organisms:ten-years experience in a single center[J]. Ren Fail. 2021;43(1):993–1003.CrossRefPubMedPubMedCentral
40.
go back to reference Cho Y, Struijk DG. Peritoneal dialysis–related peritonitis: atypical and resistant organisms[J]. Semin Nephrol. 2017;37(1):66–76.CrossRefPubMed Cho Y, Struijk DG. Peritoneal dialysis–related peritonitis: atypical and resistant organisms[J]. Semin Nephrol. 2017;37(1):66–76.CrossRefPubMed
41.
go back to reference Karaman R, Jubeh B, Breijyeh Z. Resistance of gram-positive bacteria to current antibacterial agents and overcoming approaches [J]. Molecules. 2020;25(12):2888.CrossRefPubMedPubMedCentral Karaman R, Jubeh B, Breijyeh Z. Resistance of gram-positive bacteria to current antibacterial agents and overcoming approaches [J]. Molecules. 2020;25(12):2888.CrossRefPubMedPubMedCentral
42.
go back to reference Li P, K,CHOW K M,CHO, Y. al.ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment[J]. Perit Dial Int. 2022;42(2):110–53.CrossRefPubMed Li P, K,CHOW K M,CHO, Y. al.ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment[J]. Perit Dial Int. 2022;42(2):110–53.CrossRefPubMed
43.
go back to reference Li et al. Qing,Zheng. A pathogenetic role for M1 macrophages in peritoneal dialysis-associated fibrosis.[J].Mol Immunol,2018,94:131–139. Li et al. Qing,Zheng. A pathogenetic role for M1 macrophages in peritoneal dialysis-associated fibrosis.[J].Mol Immunol,2018,94:131–139.
44.
go back to reference Yang L, Gong N, Jiang J, et al. Pathogenic bacteria and prognostic risk factors of intractable peritoneal dialysis related peritonitis[J]. J Practical Med. 2019;40(4):620–6. Yang L, Gong N, Jiang J, et al. Pathogenic bacteria and prognostic risk factors of intractable peritoneal dialysis related peritonitis[J]. J Practical Med. 2019;40(4):620–6.
45.
go back to reference Wang HH, Huang CH, Kuo MC, et al. Microbiology of peritoneal dialysis-related infection and factors of refractory peritoneal dialysis related peritonitis: a ten-year single-center study in Taiwan[J]. J Microbiol Immunol Infect. 2019;52(5):752–9.CrossRefPubMed Wang HH, Huang CH, Kuo MC, et al. Microbiology of peritoneal dialysis-related infection and factors of refractory peritoneal dialysis related peritonitis: a ten-year single-center study in Taiwan[J]. J Microbiol Immunol Infect. 2019;52(5):752–9.CrossRefPubMed
Metadata
Title
Pathogenic spectrum and risk factors of peritoneal dialysis-associated peritonitis: a single-center retrospective study
Authors
Linshuang You
Baoguo Zhang
Fan Zhang
Jianwen Wang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09334-9

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.